Nicole Baker of Biologit aims to help keep patients safe by simplifying the detection of adverse events from drug development to post-market by automating the task of monitoring scientific literature. Read more on siliconrepublic.com.
Nicole Baker of Biologit aims to help keep patients safe by simplifying the detection of adverse events from drug development to post-market by automating the task of monitoring scientific literature. Read more on siliconrepublic.com.
New Frontiers is a nationwide Enterprise Ireland programme, co-funded by the European Regional Development Fund (ERDF). Enterprise Ireland is the trade and innovation agency of the Irish Government.
This website uses cookies to improve site performance and analyse our traffic. For more information about our use of cookies, please read our Cookie policy.
Read more about GDPR / Review our Personal Data Protection Notice / Find out more about Enterprise Ireland's Grants Data Protection Notice.
© 2014-2024 Enterprise Ireland | newfrontiers.ie is the national website for the New Frontiers programme | Sign up for the New Frontiers LinkedIn newsletter | Review our data and privacy policies | Content Agency